Exact Sciences Announces Fourth Quarter 2020 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/5/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
Exact Sciences (EXAS) Q4 Revenue Tops Consensus
February 16, 2021 4:20 PM ESTExact Sciences (NASDAQ: EXAS) reported Q4 EPS of ($2.79), may not compare to the analyst estimate of ($0.22). Revenue for the quarter came in at $466.3 million versus the consensus estimate of $446.22 million.
For earnings history and earnings-related data on Exact Sciences (EXAS) click here.
... More